YA

Yashovardhan Araveti

Active Director Director DIN 11125381
DIN 11125381 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Yashovardhan Araveti

Data last updated:

Yashovardhan Araveti is a Director at Pheresis Health Care Private Limited (since 2025). The company operates in Healthcare.

DIN 11125381
Primary Designation Director
Industry Healthcare
First Appointment 26 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pheresis Health Care Private Limited U86100KA2025PTC203342
Director26 May 20252025Active

Board colleagues of Yashovardhan Araveti

NameDINCompanyDesignation
Donti Ramakrishna Anusha11125382Pheresis Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pheresis Health Care Private Limited
Premium access

Shareholding and investment profile for Yashovardhan Araveti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yashovardhan Araveti

Yashovardhan Araveti currently holds 1 directorship: Pheresis Health Care Private Limited (Director, since 26 May 2025).

Yashovardhan Araveti was first appointed on 26 May 2025 as Director at Pheresis Health Care Private Limited.

The current boards of Yashovardhan Araveti's companies include Donti Ramakrishna Anusha (Pheresis Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available